$339.74
Value $84.2B
SHW and UROY stock compared: price, dividend, valuation and results, from SEC filings.
$339.74
Value $84.2B
$2.32
Value $875M
Sherwin-Williams (SHW) has a market value of $84.2B and Uranium Royalty (UROY) $875M. Over the last year, with dividends, SHW moved +5.9% and UROY -28.5%. The P/E is 31.5 for SHW and 15.8 for UROY. Dividend yield: SHW 0.94%, UROY none.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
SHW$84.2B
UROY$875M
SHW is 96 times UROY
Revenue, 12 months
SHW$24.9B
UROY$214M
SHW is 117 times UROY
Net income, 12 months
SHW$2.7B
UROY$55M
SHW is 48 times UROY
Operating margin
SHW–
UROY29.3%
ROIC
SHW17.7%
UROY11.9%
5.8 points apart
P/E
SHW31.5
UROY15.8
SHW is 2.0 times UROY
Dividend yield
SHW0.9%
UROY0.0%
0.9 points apart
5-year return
SHW+7.6%
UROY-49.9%
57.5 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
SHW+7.6%
UROY-49.9%
| Period | SHWWith dividends | UROYWith dividends |
|---|---|---|
| 1 year since November 18, 2025 | +5.9%Price +4.9% | -28.5%Price -28.5% |
| 3 years since November 17, 2023 | +29.1%+8.9% a yearPrice +25.7% | -14.2%-5.0% a yearPrice -14.2% |
| 5 years since November 18, 2021 | +7.6%+1.5% a yearPrice +2.7% | -49.9%-12.9% a yearPrice -49.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
SHWSherwin-WilliamsUROYUranium Royalty
| Price | $339.74 | $2.32 |
|---|---|---|
| Market value | $84.2B | $875M |
| Enterprise value (EV) | $94.2B | $1.4B |
| P/E | 31.5 | 15.8 |
| P/E, 5-year median | 32.2 | – |
| P/B | 21.2 | 0.9 |
| EV/EBIT | 27.0 | 22.4 |
| Free cash flow yield | 3.7% | 23.8% |
| Revenue, 12 months | $24.9B | $214M |
|---|---|---|
| Net income, 12 months | $2.7B | $55M |
| Free cash flow, 12 months | $3.1B | $208M |
| Earnings per share, 12 months | $10.88 | $0.15 |
| Revenue growth, year on year | 2.1% | 1,566.0% |
| Revenue growth a year, past | +5.1%over 5 years | +144.7%over 2 years |
| EPS growth a year, past | +6.9%over 5 years | +55.5%over 2 years |
| Gross margin | 48.6% | 32.8% |
|---|---|---|
| Operating margin | – | 29.3% |
| Net margin | 10.7% | 26.0% |
| ROIC | 17.7% | 11.9% |
| ROE | 62.9% | 14.6% |
| Cash | $264M | $54M |
|---|---|---|
| Total debt | $12.5B | $576M |
| Net debt / EBITDA | 2.6 | 8.3 |
| Interest cover | 6.5× | 125.2× |
| Dividend yield | 0.9% | – |
|---|---|---|
| Dividend per share, 12 months | $3.20 | – |
| Dividend growth a year, past | +12.1%over 5 years | – |
| Buyback yield | 2.0% | – |
| Shareholder yield | 2.9% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Sherwin-Williams ($84.2B) is about 96.2 times Uranium Royalty ($875M), at today's prices.
Since November 18, 2021, SHW's price moved +2.7% and UROY's -49.9%. With dividends: SHW +7.6% (+1.5% a year), UROY -49.9% (-12.9% a year). Past returns do not predict future ones.
The dividend yield at today's price is 0.94% for Sherwin-Williams and none for Uranium Royalty. Over the last twelve months they paid $3.20 and – per share.
At today's price, the P/E is 31.5 for SHW and 15.8 for UROY. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 10.7% for Sherwin-Williams and 26.0% for Uranium Royalty, and the operating margin – and 29.3%. Revenue was $24.9B and $214M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.